To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Additional recommended knowledge
5-MeO-DALT is usually taken orally at dosages of 12-25mg.
5-MeO-DALT produces rapid, intense entheogenic effects, and it is very short-acting; effects are usually over within 2-4 hours. According to many users, the compound is said to be completely void of visual/hallucinogenic activity, unlike other closely related substances.
There have been no reported deaths or hospitalizations from 5-MeO-DALT, but its safety profile is unknown.
5-MeO-DALT is unscheduled and uncontrolled in the United States, but possession and sales of 5-MeO-DALT could be prosecuted under the Federal Analog Act because of its structural similarities to other Schedule I substances.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "5-MeO-DALT". A list of authors is available in Wikipedia.|